Mersana Therapeutics, Inc. (MRSN) Financials

MRSN Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 62.7 million 122.2 million
June 30, 2025 84.6 million 137.7 million
March 31, 2025 112.5 million 143.3 million
Dec. 31, 2024 144.7 million 154.2 million

MRSN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 -3.2 million 1.2 million
June 30, 2025 -22.6 million 2.0 million
March 31, 2025 -29.3 million 2.8 million
Dec. 31, 2024 -19.3 million 3.3 million

MRSN Net Income

No data available :(

MRSN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 56.4 million - 2.3 million
June 30, 2025 77.0 million - 3.3 million
March 31, 2025 102.3 million 8.2 million 4.2 million
Dec. 31, 2024 134.6 million 12.2 million 5.1 million

MRSN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 5.0 million
June 30, 2025 5.0 million
March 31, 2025 5.0 million
Dec. 31, 2024 4.9 million

MRSN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 - 12.2 million 6.3 million -
June 30, 2025 - 16.2 million 7.4 million -
March 31, 2025 - 18.3 million 8.9 million -
Dec. 31, 2024 - 22.3 million 8.9 million -

MRSN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 11.0 million -
June 30, 2025 3.1 million 287000
March 31, 2025 2.8 million -
Dec. 31, 2024 16.4 million 400000

MRSN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MRSN

Price: $29.08

52 week price:
5.21
36.25

Earnings Per Share: -13.95 USD

P/E Ratio: -2.11

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 915100

Ebitda: -7.8 million

Market Capitalization: 147.0 million

Links: